Skip to content
healthcare.dev

Insulin Aspart

NDC 73070-100, insulin aspart, injection, solution, from Novo Nordisk Pharma, Inc..

Product NDC
73070-100
Status
Listed
Labeler
Novo Nordisk Pharma, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA020986
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73070-100 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INSULIN ASPART100 [iU]/mL

Pharmacologic classes

Insulin Analog [EPC]; Insulin [CS]

Package NDCNDC-11Package
73070-100-11730700100111 VIAL, GLASS in 1 CARTON (73070-100-11) / 10 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/bee5b358-c863-420b-be73-ced2e920c499
  • NADAC price for package 73070010011

    GET /v1/drugs/nadac/73070010011

Use it

Look up 73070-100 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73070-100 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73070-100. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.